User satisfaction with an intrauterine system containing 52 mg levonorgestrel: a Portuguese study: The European Journal of Contraception & Reproductive Health Care: Vol 0, No 0
Abstract
Purpose
To characterize patient satisfaction 6 and 12 months after insertion of the 52 mg levonorgestrel-releasing intrauterine system (LNG-IUS) in Portuguese women.
Study design
A non-interventional and prospective study was conducted in Portuguese women of reproductive age who had Levosert® entered. Two questionnaires (administered 6 and 12 months after 52 mg LNG-IUS insertion) were used to collect information on patients’ menstrual pattern, discontinuation rate, and satisfaction rate with Levosert®.
Results
A total of 102 women were enrolled, of whom only 94 (92.2%) completed the study. Seven participants discontinued use of the 52 mg LNG-IUS. At 6 and 12 months, 90.7% and 90.4% of participants, respectively, were satisfied or very satisfied with the 52 mg LNG-IUS. At 6 and 12 months, 73.2% and 72.3% of participants, respectively, indicated that they would likely recommend the 52 mg LNG-IUS to a friend or family member. Most women (92.2%) continued to use the 52 mg LNG-IUS during the first year. The percentage of women who are ‘more satisfied’ with Levosert® than their previous methods of contraception were 55.9% and 57.8% at 6 and 12 months, respectively, in each questionnaire assessment. Satisfaction is related to age (p= 0.004), amenorrhea (p<0.003) and absence of dysmenorrhoea (p= 0.003), but not with parity (p= 0.922).
Conclusions
These data suggest that continuation and satisfaction rates with Levosert® is very high, and this system is well received by Portuguese women. Patient satisfaction is driven by a favorable bleeding pattern and absence of dysmenorrhoea.
Short Condensation
Satisfaction with the 52 mg levonorgestrel-releasing intrauterine system is high among Portuguese women. Patient satisfaction is primarily driven by a favorable bleeding pattern and absence of dysmenorrhoea.
Disclosure statement
No potential conflicts of interest are reported by the author(s).
Reprints and Company Permissions
Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page
How do I view content?
To request reprint or company permissions for this article, please click on the relevant link below:
Academic Permissions
Reminder: Choosing permissions is not provide access to the full text of the article, please see our help page How do I view content?
Get permissions instantly through Rightslink by clicking the button below:
If you are unable to obtain permissions through Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
